Whitney Henry

Whitney Henry is a Fellow at the Massachusetts Institute of Technology, affiliated with the Department of Biology. Her research focuses on ferroptosis, an iron-dependent form of cell death, with a particular emphasis on its role in cancer. Henry investigates molecular factors influencing ferroptosis susceptibility, its impact on the tumor microenvironment, and methods to modulate ferroptosis resistance. Her work integrates functional genomics, metabolomics, bioengineering, and in vitro and in vivo models to advance therapeutic strategies. She is also associated with the Koch Institute for Integrative Cancer Research and holds the title of Robert A. Swanson (1969) Career Development Professor of Life Sciences.

Whitney Henry is a Postdoctoral Associate at the Whitehead Institute for Biomedical Research, focusing on Cancer Biology, particularly Ovarian Cancer, Chemoresistance, and Cell Signaling. Their research explores mechanisms of ferroptosis susceptibility and evasion in cancer cells, with a focus on lipid metabolism, iron homeostasis, and signaling pathways such as PI3K, AMPK, and mTORC1. Henry's work also investigates the role of inflammation, immune cell identity, and lipidomics in cancer progression and therapeutic resistance. By integrating molecular and cellular approaches, their studies aim to identify novel targets for improving cancer treatment outcomes.